BRIAN GAYNOR: The rise and rise of Fisher & Paykel Healthcare

BRIAN GAYNOR: The rise and rise of Fisher & Paykel Healthcare
Brian Gaynor
Fisher & Paykel Healthcare has been a fantastic investment in recent years, particularly during the covid-19 pandemic.At the end of June, the medical supplies company had a share market value of $20.5 billion, making it the first $20 billion NZX company. Its performance during the covid-19 crisis has been amazing with its total market value surging $7.1 billion between Jan. 31 and June 30. This value accretion was greater than the total value of all but four other NZX listed stocks: A2 Milk, Meridian Energy, Auckland International...

More Opinion

The 20% question
Opinion

David Chaplin: The 20% question

KiwiSavers' average per member is better than nothing, but probably not enough.

Polarisation: from talkback to the trading desk
Opinion

Dileepa Fonseka: Polarisation: from talkback to the trading desk

Political polarisation is becoming more of a worry for NZ investors.

Dileepa Fonseka 15 Sep 2025
The All’s, the In’s, the outs and AI …
Opinion

Simon Robertson: The All’s, the In’s, the outs and AI …

Discussing the future of the West and humanity is bone-chilling.

Simon Robertson 13 Sep 2025
Search and rescue: Google given a lifeline
Opinion

Peter Griffin: Search and rescue: Google given a lifeline

The digital economy deserves more than ceremonial change.

Peter Griffin 10 Sep 2025